Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-13

FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved Biocon Pharma Inc.'s supplemental application for mycophenolic acid, granting approval of the generic product under ANDA214630. This establishes Bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycophenolic acid (mycophenolic acid)

Snippet

SUPPL AP for MYCOPHENOLIC ACID (MYCOPHENOLIC ACID)